glp 1 ilaçları GLP-1 Agonistleri (Zayıflama İğneleri), 4 Kanser Türünde Metastaz Riskini Azalttı GLP-1 İlaçları: Kanser Riskini Artırıyor
Description
uses Supergut GLP-1 Booster to control cravings and improve digestion
Diabetes leads to a significantly accelerated incidence of various related macrovascular complications, including peripheral vascular disease and cardiovascular disease (the most common cause of mortality in diabetes), as well as microvascular complications such as kidney disease and retinopathy
Women on GLP-1 drugs had an 8% lower risk of obesity-related cancers and a 20% lower risk of death from any cause, compared to those taking #DPP4 inhibitors
These trends suggest that GLP-1s are reshaping treatment patterns most significantly in markets where few alternatives exist and where their effectiveness is increasingly valued
Who are GLP-1 medications for
